Global Remote Patient Monitoring Devices Market

Global Remote Patient Monitoring Devices Market Size, Share, Growth Analysis, By Type(Devices, Services), By Application(Oncology, Diabetes Cardiovascular Diseases), By End-User(Payers, Providers) - Industry Forecast 2024-2031


Report ID: SQMIG35A2717 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 89 | Figures: 76

Global Remote Patient Monitoring Devices Market Dynamics

Remote Patient Monitoring Devices Market Drivers

Increase in Population with Chronic Illnesses:

  • By the year 2050, there will be 1.5 billion elderly people worldwide, according to the World Health Organization (WHO). During 2021–2028, it is also predicted that the prevalence of chronic illnesses affecting the older population would rise. Therefore, there is a growing demand for ongoing vital sign monitoring and efficient illness treatment. For instance, about 70% of elderly persons in India suffer from a chronic condition. About 18% of people between the ages of 45 and 49 have hypertension, which rises to 28% among people between the ages of 60 and 64 and 35% among people between the ages of 70 and 74. Diabetes and bone or joint problems are also some common problems among the elderly.
  • The COVID-19 pandemic has prompted the introduction of cutting-edge technology solutions that can assist with managing medications, tracking illness symptoms, and remote monitoring of vital signs. More health indicators may be examined as the next-generation patient monitoring technologies get more comprehensive. Consumers are increasingly drawn to using technology-driven systems and products. Wearables, most frequently a smartwatch, are used by 57 percent of women and 43 percent of men during the day, primarily to track their vitals and stay in shape.

Remote Patient Monitoring Devices Market Restraint

Distribution of Technologies to Create an Imbalance

  • The U.S. has implemented legislative and payment adjustments to promote patient virtual monitoring, whilst such technologies are unavailable in countries with low-income groups. Another issue impeding the growth of the remote patient monitoring devices is the lack of knowledge among healthcare practitioners, restricted access to high-quality healthcare, and poor internet connection in low-to-middle-income countries (LMICs).
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Remote Patient Monitoring Devices Market size was valued at USD 3.13 billion in 2019 and is poised to grow from USD 4.4 billion in 2023 to USD 28.85 billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031).

The global remote patient monitoring devices market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For example, the Onyx Frontier drug-eluting stent has been approved by the U.S. Food and Drug Administration (FDA), according to Medtronic plc, a world leader in healthcare technology. Onyx Frontier DES, the newest member of the Resolute DES family, utilizes the same best-in-class stent technology as Resolute Onyx and has an improved distribution method that is intended to maximize acute performance in even the most difficult patients. 'Medtronic plc', 'Koninklijke Philips N.V.', 'GE Healthcare Inc.', 'Abbott Laboratories', 'Boston Scientific Corporation', 'Nihon Kohden Corporation', 'Omron Corporation', 'Masimo Corporation', 'BioTelemetry, Inc.', 'Hill-Rom Holdings, Inc.', 'Smiths Group plc', 'ResMed Inc.', 'Biotronik SE & Co. KG', 'AliveCor, Inc.', 'iRhythm Technologies, Inc.', 'Welch Allyn, Inc.', 'General Electric Company', 'Nonin Medical Inc.', 'Honeywell International Inc.', 'McKesson Corporation'

North America accounted for the highest portion of the global remote patient monitoring devices market in 2022. Higher use of these monitoring devices by patients and hospital settings characterizes the market in the region. Furthermore, the region's leading market position in 2022 is due to increasing investment in the introduction of advanced technology for high-quality patient care. Furthermore, a large population in the region suffering from chronic diseases is boosting the demand for various medical devices. About 133 million Americans suffer from chronic illnesses, accounting for more than 40% of the nation's population.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Remote Patient Monitoring Devices Market

Product ID: SQMIG35A2717

$5,300
BUY NOW GET FREE SAMPLE